• OPEN AN ACCOUNT
Indian Indices
Nifty
24,968.40 -143.05
(-0.57%)
Sensex
82,018.61 260.88
( 0.32%)
Bank Nifty
56,283.00 -545.80
( -0.96%)
Nifty IT
37,141.85 3.30
( 0.01%)
Global Indices
Nasdaq
44,363.41 142.09
(-0.32%)
Dow Jones
6,317.35 -1.01
(-0.02%)
Hang Seng
39,788.57 -112.62
(-0.28%)
Nikkei 225
8,992.12 19.48
(0.22%)
Forex
USD-INR
85.99 0.08
(0.09%)
EUR-INR
99.75 -0.09
(-0.09%)
GBP-INR
115.25 0.11
(0.09%)
JPY-INR
0.58 0.00
(0.02%)

EQUITY - MARKET SCREENER

Aurangabad Distillery Ltd
Industry :  Breweries & Distilleries
BSE Code
ISIN Demat
Book Value()
538379
INE448V01019
94.0195122
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AURDIS
17.58
157.65
EPS(TTM)
Face Value()
Div & Yield %
8.75
10
0
 

Shilpa Medicare's Unit VI clears USFDA inspection
Jul 16,2025
Shilpa Medicare announced that its Unit VI, Dabaspet, Bengaluru, has received EIR with VAI (Voluntary Action Indicated) classification, from USFDA, for the GMP inspection which was conducted from 24-30 October 2024.

This facility is capable of manufacturing, packaging, testing, storage and distribution of two types of complex dosage forms - Oral Dissolving Films and Transdermal Systems.

The Unit is already approved by EMA, Europe; MHRA, UK; SFDA, Saudi and TGA, Australia.

This Unit is currently supplying Oral Film products to US and other markets. Transdermal products have been filed in the European market.